亚宝药业：12月19日召开董事会会议

Group 1 - The company, Yabao Pharmaceutical, announced that its 12th meeting of the 9th Board of Directors was held on December 19, 2025, via telecommunication voting, where it reviewed the proposal for the 2026 first extraordinary shareholders' meeting [1] - For the year 2024, Yabao Pharmaceutical's revenue composition is as follows: pharmaceutical manufacturing accounts for 75.46%, pharmaceutical wholesale accounts for 21.37%, other trade accounts for 1.88%, and other businesses account for 1.29% [1] - As of the report date, Yabao Pharmaceutical has a market capitalization of 4.6 billion yuan [1]